FDA NDC Directory · JSON-LD · Markdown

Ciprofloxacin

NDC 25021-192 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameciprofloxacin
Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA078252
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsCIPROFLOXACIN (2 mg/mL)
Marketing started20221215
Package count2

External sources

Source: openFDA. Public-domain (CC0).